NY State Senate Bill 2013-S1976B

Senate Bill S1976B

2013-2014 Legislative Session

Provides a program to promote leukemia, lymphoma and myeloma research, education and treatment and establishes the leukemia, lymphoma and myeloma research, education and treatment fund

download bill text pdf

Archive: Last Bill Status - In Senate Committee Health Committee

Introduced
- In Committee Assembly
- In Committee Senate
- On Floor Calendar Assembly
- On Floor Calendar Senate
- Passed Assembly
- Passed Senate
Delivered to Governor
Signed By Governor

Please enter your contact information

First Name

Last Name

Email Address

A valid email address is required.

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

View Actions

	Assembly Actions - Lowercase Senate Actions - UPPERCASE
Feb 10, 2014	print number 1976b
Feb 10, 2014	amend and recommit to health
Jan 08, 2014	referred to health
May 22, 2013	print number 1976a
May 22, 2013	amend and recommit to health
Jan 09, 2013	referred to health

Bill Amendments

Original

B (Active)

co-Sponsors

2013-S1976 - Details

See Assembly Version of this Bill:: A558
Current Committee:: Senate Health
Law Section:: Public Health Law
Laws Affected:: Add Art 27-CCC §2747, Pub Health L; add §§209-I & 630-d, Tax L; add §97-llll, St Fin L
Versions Introduced in Other Legislative Sessions:: 2009-2010: S1197, A3075
2011-2012: S569, A283
2015-2016: A49
2017-2018: A1354
2019-2020: A4481

2013-S1976 - Summary

Provides a program to promote leukemia, lymphoma and myeloma research, education and treatment and establishes the leukemia, lymphoma and myeloma research, education and treatment fund; authorizes the commissioner of taxation and finance to create a check-off gift on individual income tax returns for contributions to leukemia, lymphoma and myeloma research, education and treatment.

2013-S1976 - Sponsor Memo

                                BILL NUMBER:S1976

TITLE OF BILL:
An act
to amend the public health law, the
tax law and the state finance law, in relation to providing
for taxpayer gifts for leukemia, lymphoma and myeloma
research, education and treatment and establishing
the leukemia, lymphoma and myeloma
research, education and treatment fund

PURPOSE:
The purpose of this bill is to provide easy access to help fund and
support Leukemia, Lymphoma and Myeloma research, education and
treatment.

SUMMARY OF PROVISIONS:

Section 1 - Amends the public health law by adding a new article
27-CCC, The new article provides the Commissioner of Health with the
powers to: develop programs concerning Leukemia, Lymphoma, and
Myeloma, to accept and expend grants. awards and other funding, and
to enter into contracts necessary for program development and
granting. Section 2 - Amends the law by adding a new section 209-B.
The new section provides for the Commissioner of Taxation and Finance
to include a space on the corporate income tax return for

contributions to Leukemia, Lymphoma, and Myeloma research. education
and treatment. Section 3 - Amends part 2 of article 22 of the tax law
by adding new section 630-c. The new section provides for the
Commissioner of Taxation and Finance to include a space on the
individual income tax return for contributions to Leukemia, Lymphoma,
and Myeloma research. education and treatment. Section 4 - Amends the
state finance law by adding a new section 97-1111. The new section
provides for the establishment of a special fund. consisting of
revenues received under section 209-H and 630-c of the tax law and
any other moneys appropriated. credited or transferred, for Leukemia,
Lymphoma and Myeloma research, education and treatment.
The custody of this fund will be held jointly by the Commissioner of
Taxation and Finance and the Comptroller. Further, the new section
provides that all monies in the fund to be used only for Leukemia,
Lymphoma and Myeloma research, education and treatment programs
approved by the Department of Health. Additionally, the new section
provides that the Comptroller must approve releases of money that are
certified by the Commissioner of Health and that all money in the
fund should be used prior to the end of the fiscal year.

JUSTIFICATION:
Research and treatment efforts for many diseases, including
Alzheimer's and breast cancer, have benefited from additional funding
resulting from having a "check-off box" placed on the individual and
corporate income tax returns. Leukemia, Lymphoma and Myeloma are

blood cancers originating
in the bone marrow and correlate with each other because of the
unrestrained growth of the cells and the parallel functions which
they possess. Leukemia. although more common in adults over the age
of 64, is still the leading cause of disease death of children under
15 yrs old, with Acute Lymphocytic Leukemia (ALL) being the most
common form of Leukemia in children. Treatment advances for Leukemia
have proven to be prevalent in the survival rate over the years, with
the survival rate increasing from 4% in 1960 to 85% in 1999. Lymphoma
involves two particular forms including Non-Hodgkin. which is the
fifth most common cancer in the U.S. and Hodgkin Lymphoma, which
mostly affects adolescents and young adults. Myeloma occurs mostly in
people over 60 yrs old with males having a 50% higher chance than
females of being diagnosed. Each year an estimated 106,200 people in
the United States are diagnosed with Leukemia, Lymphoma, or Myeloma.
At the present time. an estimated 670,950 Americans have blood
cancers. Approximately 57,500 Americans will die from these
hematological malignancies this year. In New York State alone, there
are approximately 6,600 people diagnosed with a blood cancer each
year and 3,500 people will succumb to this
disease.

PRIOR LEGISLATIVE HISTORY:
2011 - 2012 S.569 Referred to Health

FISCAL IMPLICATIONS: Minimal to the state.

EFFECTIVE DATE:
This act shall apply to taxable years commencing on or after January
1, 2015.

2013-S1976 - Bill Text download pdf

                            
                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                  1976

                       2013-2014 Regular Sessions

                            I N  S E N A T E

                               (PREFILED)

                             January 9, 2013
                               ___________

Introduced  by  Sen.  ROBACH -- read twice and ordered printed, and when
  printed to be committed to the Committee on Health

AN ACT to amend the public health law, the tax law and the state finance
  law, in relation to providing for taxpayer gifts for leukemia, lympho-
  ma and myeloma research, education and treatment and establishing  the
  leukemia, lymphoma and myeloma research, education and treatment fund

  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1. The public health law is amended by adding  a  new  article
27-CCC to read as follows:
                             ARTICLE 27-CCC
LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION AND TREATMENT PROGRAM
SECTION  2747.  LEUKEMIA,  LYMPHOMA  AND MYELOMA RESEARCH, EDUCATION AND
               TREATMENT.
  S 2747. LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION AND  TREAT-
MENT.   THE COMMISSIONER SHALL ESTABLISH WITHIN THE DEPARTMENT A PROGRAM
TO PROMOTE RESEARCH, EDUCATION AND TREATMENT REGARDING LEUKEMIA, LYMPHO-
MA AND MYELOMA. TO CARRY OUT THE PURPOSES OF THIS SECTION,  THE  COMMIS-
SIONER SHALL HAVE THE FOLLOWING POWERS AND DUTIES:
  1.  TO  PROMOTE RESEARCH, EDUCATION AND TREATMENT PROGRAMS DESIGNED TO
REDUCE OR PREVENT THE INCIDENCE AND SEVERITY OF LEUKEMIA,  LYMPHOMA  AND
MYELOMA;
  2. TO ACCEPT AND EXPEND ANY GRANTS, AWARDS OR OTHER FUNDS OR APPROPRI-
ATIONS  AS MAY BE AVAILABLE FOR THESE PURPOSES SUBJECT TO LIMITATIONS AS
TO THE APPROVAL OF EXPENDITURES AND AUDIT AS PRESCRIBED FOR STATE  FUNDS
BY THE STATE FINANCE LAW; AND
  3.  TO  ENTER  INTO CONTRACTS WITHIN THE AMOUNTS AVAILABLE THEREFOR AS
MAY BE NECESSARY TO IMPLEMENT THE PROVISIONS OF THIS SECTION.
  S 2. The tax law is amended by adding a new section 209-H to  read  as
follows:

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.

                                                           LBD00819-01-3

S. 1976                             2

  S  209-H.  GIFT FOR LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION
AND TREATMENT.  EFFECTIVE FOR ANY TAX YEAR COMMENCING ON OR AFTER  JANU-
ARY  FIRST,  TWO  THOUSAND  FIFTEEN,  A TAXPAYER IN ANY TAXABLE YEAR MAY
ELECT TO CONTRIBUTE TO THE SUPPORT OF THE LEUKEMIA, LYMPHOMA AND MYELOMA
RESEARCH,  EDUCATION  AND  TREATMENT FUND. SUCH CONTRIBUTION SHALL BE IN
ANY WHOLE DOLLAR AMOUNT AND SHALL NOT REDUCE THE AMOUNT OF THE STATE TAX
OWED BY SUCH TAXPAYER. THE  COMMISSIONER  SHALL  INCLUDE  SPACE  ON  THE
CORPORATE  INCOME  TAX RETURN TO ENABLE A TAXPAYER TO MAKE SUCH CONTRIB-
UTION.  NOTWITHSTANDING  ANY  OTHER  PROVISION  OF  LAW,  ALL   REVENUES
COLLECTED  PURSUANT  TO  THIS SECTION SHALL BE CREDITED TO THE LEUKEMIA,
LYMPHOMA AND MYELOMA RESEARCH, EDUCATION AND TREATMENT FUND AND SHALL BE
USED ONLY FOR THOSE PURPOSES ENUMERATED IN SECTION NINETY-SEVEN-LLLL  OF
THE STATE FINANCE LAW.
  S  3.  The tax law is amended by adding a new section 630-c to read as
follows:
  S 630-C. GIFT FOR LEUKEMIA, LYMPHOMA AND MYELOMA  RESEARCH,  EDUCATION
AND  TREATMENT.  EFFECTIVE FOR ANY TAX YEAR COMMENCING ON OR AFTER JANU-
ARY FIRST, TWO THOUSAND FIFTEEN, AN INDIVIDUAL IN ANY TAXABLE  YEAR  MAY
ELECT  TO  CONTRIBUTE  TO  THE  LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH,
EDUCATION AND TREATMENT FUND. SUCH CONTRIBUTION SHALL BE  IN  ANY  WHOLE
DOLLAR  AMOUNT AND SHALL NOT REDUCE THE AMOUNT OF STATE TAX OWED BY SUCH
INDIVIDUAL. THE COMMISSIONER SHALL INCLUDE SPACE ON THE PERSONAL  INCOME
TAX  RETURN  TO  ENABLE  A TAXPAYER TO MAKE SUCH CONTRIBUTION.  NOTWITH-
STANDING ANY OTHER PROVISION OF LAW ALL REVENUES COLLECTED  PURSUANT  TO
THIS  SECTION  SHALL  BE  CREDITED TO THE LEUKEMIA, LYMPHOMA AND MYELOMA
RESEARCH, EDUCATION AND TREATMENT FUND AND USED ONLY FOR THOSE  PURPOSES
ENUMERATED IN SECTION NINETY-SEVEN-LLLL OF THE STATE FINANCE LAW.
  S  4. The state finance law is amended by adding a new section 97-llll
to read as follows:
  S 97-LLLL. LEUKEMIA, LYMPHOMA  AND  MYELOMA  RESEARCH,  EDUCATION  AND
TREATMENT  FUND.  1. THERE IS HEREBY ESTABLISHED IN THE JOINT CUSTODY OF
THE COMMISSIONER OF TAXATION AND FINANCE AND THE COMPTROLLER, A  SPECIAL
FUND TO BE KNOWN AS THE "LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCA-
TION AND TREATMENT FUND".
  2.  SUCH FUND SHALL CONSIST OF ALL REVENUES RECEIVED BY THE DEPARTMENT
OF TAXATION AND FINANCE, PURSUANT  TO  THE  PROVISIONS  OF  SECTION  TWO
HUNDRED  NINE-H  AND SECTION SIX HUNDRED THIRTY-C OF THE TAX LAW AND ALL
OTHER MONEYS APPROPRIATED, CREDITED, OR  TRANSFERRED  THERETO  FROM  ANY
OTHER  FUND OR SOURCE PURSUANT TO LAW. NOTHING CONTAINED IN THIS SECTION
SHALL PREVENT THE STATE FROM RECEIVING GRANTS, GIFTS OR BEQUESTS FOR THE
PURPOSES OF THE FUND AS DEFINED IN THIS SECTION AND DEPOSITING THEM INTO
THE FUND ACCORDING TO LAW.
  3. MONIES OF THE FUND SHALL BE EXPENDED ONLY  FOR  LEUKEMIA,  LYMPHOMA
AND  MYELOMA RESEARCH, EDUCATION AND TREATMENT PROJECTS. AS USED IN THIS
SECTION, "LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION AND  TREAT-
MENT PROJECTS" MEANS RESEARCH, EDUCATION AND TREATMENT PROJECTS, INCLUD-
ING  GRANTS  FOR  LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION AND
TREATMENT, WHICH, PURSUANT TO SECTION TWENTY-SEVEN  HUNDRED  FORTY-SEVEN
OF  THE  PUBLIC  HEALTH  LAW,  ARE APPROVED BY THE DEPARTMENT OF HEALTH.
SUCH GRANTS MAY INCLUDE, AMONG OTHERS,  GRANTS  TO  PUBLIC  AND  PRIVATE
HOSPITALS, MEDICAL CENTERS, MEDICAL SCHOOLS AND OTHER ORGANIZATIONS.
  4.  MONIES  SHALL BE PAYABLE FROM THE FUND ON THE AUDIT AND WARRANT OF
THE COMPTROLLER ON VOUCHERS APPROVED AND CERTIFIED BY  THE  COMMISSIONER
OF HEALTH.

S. 1976                             3

  5.  TO THE EXTENT PRACTICABLE, THE COMMISSIONER OF HEALTH SHALL ENSURE
THAT ALL MONIES RECEIVED DURING A FISCAL YEAR ARE EXPENDED PRIOR TO  THE
END OF THAT FISCAL YEAR.
  S 5. This act shall take effect immediately and shall apply to taxable
years commencing on or after January 1, 2015.

co-Sponsors

2013-S1976A - Details

See Assembly Version of this Bill:: A558
Current Committee:: Senate Health
Law Section:: Public Health Law
Laws Affected:: Add Art 27-CCC §2747, Pub Health L; add §§209-I & 630-d, Tax L; add §97-llll, St Fin L
Versions Introduced in Other Legislative Sessions:: 2009-2010: S1197, A3075
2011-2012: S569, A283
2015-2016: A49
2017-2018: A1354
2019-2020: A4481

2013-S1976A - Summary

2013-S1976A - Sponsor Memo

                                BILL NUMBER:S1976A

TITLE OF BILL:  An act to amend the public health law, the tax law and
the state finance law, in relation to providing for taxpayer gifts for
leukemia, lymphoma and myeloma research, education and treatment and
establishing the leukemia, lymphoma and myeloma research, education
and treatment fund

PURPOSE OR GENERAL IDEA OF BILL: The purpose of this bill is to
provide easy access to help fund and support Leukemia, Lymphoma, and
Myeloma research, education and treatment.

SUMMARY OF SPECIFIC PROVISIONS: Section 1 - Amends the public health
law by adding a new article 27-CCC. The new article provides the
Commissioner of Health with the powers to: develop programs concerning
Leukemia, Lymphoma, and Myeloma, to accept and expend grants, awards
and other funding, and to enter into contracts necessary for program
development and granting. Section 2 - Amends the law by adding a new
section 209-1. The new section provides for the Commissioner of
Taxation and Finance to include a space on the corporate income tax
return for contributions to Leukemia, Lymphoma, and Myeloma research,
education and treatment. Section 3 - Amends part 2 of article 22 of
the tax law by adding new section 630-d. The new section provides for
the Commissioner of Taxation and Finance to include a space on the
individual income tax return for contributions to Leukemia, Lymphoma,
and Myeloma research, education and treatment.  Section 4 - Amends the

state finance law by adding a new section 97-llll. The new section
provides for the establishment of a special fund, consisting of
revenues received under section 209-i and 630-d of the tax law and any
other moneys appropriated, credited or transferred, for Leukemia,
Lymphoma and Myeloma research, education and treatment. The custody of
this fund will be held jointly by the Commissioner of Taxation and
Finance and the Comptroller. Further, the new section provides that
all monies in the fund to be used only for Leukemia, Lymphoma and
Myeloma research, education and treatment programs approved by the
Department of Health. Additionally, the new section provides that the
Comptroller must approve releases of money that are certified by the
Commissioner of Health and that all money in the fund should be used
prior to the end of the fiscal year.

JUSTIFICATION: Research and treatment efforts for many diseases,
including Alzheimer's and breast cancer, have benefited from
additional funding resulting from having a "check-off box" placed on
the individual and corporate income tax returns. Leukemia, Lymphoma
and Myeloma are blood cancers originating in the bone marrow and
correlate with each other because of the unrestrained growth of the
cells and the parallel functions which they possess. Leukemia,
although more common in adults over the age of 64, is still the
leading cause of disease death of children under 15 yrs old, with
Acute Lymphocytic Leukemia (ALL) being the most common form of
Leukemia in children. Treatment advances for Leukemia have proven to
be prevalent in the survival rate over the years, with the survival
rate increasing from 4% in 1960 to 85% in 1999. Lymphoma involves two
particular forms including Non-Hodgkin, which is the fifth most common
cancer in the U.S. and Hodgkin Lymphoma, which mostly affects
adolescents and young adults. Myeloma occurs mostly in people over 60
yrs old with males having a 50% higher chance than females of being


diagnosed. Each year an estimated 106,200 people in the United States
are diagnosed with Leukemia, Lymphoma, or Myeloma.  At the present
time, an estimated 670,950 Americans have blood cancers. Approximately
57,500 Americans will die from these hematological malignancies this
year. In New York State alone, there are approximately 6,600 people
diagnosed with a blood cancer each year and 3,500 people will succumb
to this disease.

PRIOR LEGISLATIVE HISTORY:  2012: A.0283-Passed Assembly S.0569- Died
in Senate Health 2011: A.0283- Passed Assembly S.0569- Died in Senate
Health 2010: A,3075-A Died on 3rd Rdg. S.1197-A - Died in Senate
Health 2009: A.3075 Passed Assembly; 2008: A.1558-C Passed Assembly;
S.3097-B - Died in Senate Health 2007: A.1558-A Passed Assembly;
S.3097-A-- Died in Senate. Health 2006: A.3338-A Passed Assembly;
S.2871-A-Died in Senate Health; 2005: A.3338-Passed Assembly; S.2878-A
Died in Senate Health 2004: A.9816-Passed Assembly; S.6491-Died in
Senate Health

FISCAL IMPLICATIONS: Minimal to the state.

EFFECTIVE DATE: This act shall apply to taxable years commencing on or
after January 1, 2015.

2013-S1976A - Bill Text download pdf

                            
                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                 1976--A

                       2013-2014 Regular Sessions

                            I N  S E N A T E

                               (PREFILED)

                             January 9, 2013
                               ___________

Introduced  by  Sens. ROBACH, BRESLIN -- read twice and ordered printed,
  and when printed to be committed to the Committee on Health -- commit-
  tee discharged, bill amended, ordered reprinted as amended and  recom-
  mitted to said committee

AN ACT to amend the public health law, the tax law and the state finance
  law, in relation to providing for taxpayer gifts for leukemia, lympho-
  ma  and myeloma research, education and treatment and establishing the
  leukemia, lymphoma and myeloma research, education and treatment fund

  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section  1.  The  public health law is amended by adding a new article
27-CCC to read as follows:
                             ARTICLE 27-CCC
LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION AND TREATMENT PROGRAM
SECTION 2747. LEUKEMIA, LYMPHOMA AND  MYELOMA  RESEARCH,  EDUCATION  AND
                TREATMENT.
  S  2747. LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION AND TREAT-
MENT.  THE COMMISSIONER SHALL ESTABLISH WITHIN THE DEPARTMENT A  PROGRAM
TO PROMOTE RESEARCH, EDUCATION AND TREATMENT REGARDING LEUKEMIA, LYMPHO-
MA  AND  MYELOMA. TO CARRY OUT THE PURPOSES OF THIS SECTION, THE COMMIS-
SIONER SHALL HAVE THE FOLLOWING POWERS AND DUTIES:
  1. TO PROMOTE RESEARCH, EDUCATION AND TREATMENT PROGRAMS  DESIGNED  TO
REDUCE  OR  PREVENT THE INCIDENCE AND SEVERITY OF LEUKEMIA, LYMPHOMA AND
MYELOMA;
  2. TO ACCEPT AND EXPEND ANY GRANTS, AWARDS OR OTHER FUNDS OR APPROPRI-
ATIONS AS MAY BE AVAILABLE FOR THESE PURPOSES SUBJECT TO LIMITATIONS  AS
TO  THE APPROVAL OF EXPENDITURES AND AUDIT AS PRESCRIBED FOR STATE FUNDS
BY THE STATE FINANCE LAW; AND
  3. TO ENTER INTO CONTRACTS WITHIN THE AMOUNTS  AVAILABLE  THEREFOR  AS
MAY BE NECESSARY TO IMPLEMENT THE PROVISIONS OF THIS SECTION.

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.

                                                           LBD00819-03-3

S. 1976--A                          2

  S  2.  The tax law is amended by adding a new section 209-I to read as
follows:
  S  209-I.  GIFT FOR LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION
AND TREATMENT.  EFFECTIVE FOR ANY TAX YEAR COMMENCING ON OR AFTER  JANU-
ARY  FIRST,  TWO  THOUSAND  FIFTEEN,  A TAXPAYER IN ANY TAXABLE YEAR MAY
ELECT TO CONTRIBUTE TO THE SUPPORT OF THE LEUKEMIA, LYMPHOMA AND MYELOMA
RESEARCH, EDUCATION AND TREATMENT FUND. SUCH CONTRIBUTION  SHALL  BE  IN
ANY WHOLE DOLLAR AMOUNT AND SHALL NOT REDUCE THE AMOUNT OF THE STATE TAX
OWED  BY  SUCH  TAXPAYER.  THE  COMMISSIONER  SHALL INCLUDE SPACE ON THE
CORPORATE INCOME TAX RETURN TO ENABLE A TAXPAYER TO MAKE  SUCH  CONTRIB-
UTION.   NOTWITHSTANDING  ANY  OTHER  PROVISION  OF  LAW,  ALL  REVENUES
COLLECTED PURSUANT TO THIS SECTION SHALL BE CREDITED  TO  THE  LEUKEMIA,
LYMPHOMA AND MYELOMA RESEARCH, EDUCATION AND TREATMENT FUND AND SHALL BE
USED  ONLY FOR THOSE PURPOSES ENUMERATED IN SECTION NINETY-SEVEN-LLLL OF
THE STATE FINANCE LAW.
  S 3. The tax law is amended by adding a new section 630-d to  read  as
follows:
  S  630-D.  GIFT FOR LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION
AND TREATMENT.  EFFECTIVE FOR ANY TAX YEAR COMMENCING ON OR AFTER  JANU-
ARY  FIRST,  TWO THOUSAND FIFTEEN, AN INDIVIDUAL IN ANY TAXABLE YEAR MAY
ELECT TO CONTRIBUTE TO THE  LEUKEMIA,  LYMPHOMA  AND  MYELOMA  RESEARCH,
EDUCATION  AND  TREATMENT  FUND. SUCH CONTRIBUTION SHALL BE IN ANY WHOLE
DOLLAR AMOUNT AND SHALL NOT REDUCE THE AMOUNT OF STATE TAX OWED BY  SUCH
INDIVIDUAL.  THE COMMISSIONER SHALL INCLUDE SPACE ON THE PERSONAL INCOME
TAX RETURN TO ENABLE A TAXPAYER TO MAKE  SUCH  CONTRIBUTION.    NOTWITH-
STANDING  ANY  OTHER PROVISION OF LAW ALL REVENUES COLLECTED PURSUANT TO
THIS SECTION SHALL BE CREDITED TO THE  LEUKEMIA,  LYMPHOMA  AND  MYELOMA
RESEARCH,  EDUCATION AND TREATMENT FUND AND USED ONLY FOR THOSE PURPOSES
ENUMERATED IN SECTION NINETY-SEVEN-LLLL OF THE STATE FINANCE LAW.
  S 4. The state finance law is amended by adding a new section  97-llll
to read as follows:
  S  97-LLLL.  LEUKEMIA,  LYMPHOMA  AND  MYELOMA RESEARCH, EDUCATION AND
TREATMENT FUND. 1. THERE IS HEREBY ESTABLISHED IN THE JOINT  CUSTODY  OF
THE  COMMISSIONER OF TAXATION AND FINANCE AND THE COMPTROLLER, A SPECIAL
FUND TO BE KNOWN AS THE "LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCA-
TION AND TREATMENT FUND".
  2. SUCH FUND SHALL CONSIST OF ALL REVENUES RECEIVED BY THE  DEPARTMENT
OF  TAXATION  AND  FINANCE,  PURSUANT  TO  THE PROVISIONS OF SECTION TWO
HUNDRED NINE-I AND SECTION SIX HUNDRED THIRTY-D OF THE TAX LAW  AND  ALL
OTHER  MONEYS  APPROPRIATED,  CREDITED,  OR TRANSFERRED THERETO FROM ANY
OTHER FUND OR SOURCE PURSUANT TO LAW. NOTHING CONTAINED IN THIS  SECTION
SHALL PREVENT THE STATE FROM RECEIVING GRANTS, GIFTS OR BEQUESTS FOR THE
PURPOSES OF THE FUND AS DEFINED IN THIS SECTION AND DEPOSITING THEM INTO
THE FUND ACCORDING TO LAW.
  3.  MONIES  OF  THE FUND SHALL BE EXPENDED ONLY FOR LEUKEMIA, LYMPHOMA
AND MYELOMA RESEARCH, EDUCATION AND TREATMENT PROJECTS. AS USED IN  THIS
SECTION,  "LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION AND TREAT-
MENT PROJECTS" MEANS RESEARCH, EDUCATION AND TREATMENT PROJECTS, INCLUD-
ING GRANTS FOR LEUKEMIA, LYMPHOMA AND MYELOMA  RESEARCH,  EDUCATION  AND
TREATMENT,  WHICH,  PURSUANT TO SECTION TWENTY-SEVEN HUNDRED FORTY-SEVEN
OF THE PUBLIC HEALTH LAW, ARE APPROVED  BY  THE  DEPARTMENT  OF  HEALTH.
SUCH  GRANTS  MAY  INCLUDE,  AMONG  OTHERS, GRANTS TO PUBLIC AND PRIVATE
HOSPITALS, MEDICAL CENTERS, MEDICAL SCHOOLS AND OTHER ORGANIZATIONS.
  4. MONIES SHALL BE PAYABLE FROM THE FUND ON THE AUDIT AND  WARRANT  OF
THE  COMPTROLLER  ON VOUCHERS APPROVED AND CERTIFIED BY THE COMMISSIONER
OF HEALTH.

S. 1976--A                          3

  5. TO THE EXTENT PRACTICABLE, THE COMMISSIONER OF HEALTH SHALL  ENSURE
THAT  ALL MONIES RECEIVED DURING A FISCAL YEAR ARE EXPENDED PRIOR TO THE
END OF THAT FISCAL YEAR.
  S 5. This act shall take effect immediately and shall apply to taxable
years commencing on or after January 1, 2015.

co-Sponsors

2013-S1976B (ACTIVE) - Details

See Assembly Version of this Bill:: A558
Current Committee:: Senate Health
Law Section:: Public Health Law
Laws Affected:: Add Art 27-CCC §2747, Pub Health L; add §§209-I & 630-d, Tax L; add §97-llll, St Fin L
Versions Introduced in Other Legislative Sessions:: 2009-2010: S1197, A3075
2011-2012: S569, A283
2015-2016: A49
2017-2018: A1354
2019-2020: A4481

2013-S1976B (ACTIVE) - Summary

2013-S1976B (ACTIVE) - Sponsor Memo

                                BILL NUMBER:S1976B

TITLE OF BILL:  An act to amend the public health law, the tax law and
the state finance law, in relation to providing for taxpayer gifts for
leukemia,  lymphoma  and myeloma research, education and treatment and
establishing the leukemia, lymphoma and  myeloma  research,  education
and treatment fund

PURPOSE OR GENERAL IDEA OF BILL:

The  purpose  of  this bill is to provide easy access to help fund and
support  Leukemia,  Lymphoma,  and  Myeloma  research,  education  and
treatment.

SUMMARY OF SPECIFIC PROVISIONS:

Section  1  -  Amends  the  public  health law by adding a new article
27-CCC. The new article provides the Commissioner of Health  with  the
powers   to:  develop  programs  concerning  Leukemia,  Lymphoma,  and
Myeloma, to accept and expend grants, awards and other funding, and to
enter into contracts necessary for program development  and  granting.
Section  2  -  Amends  the  law by adding a new section 209-1. The new
section provides for the  Commissioner  of  Taxation  and  Finance  to
include  a  space on the corporate income tax return for contributions
to Leukemia, Lymphoma, and Myeloma research, education and  treatment.
Section  3  - Amends part 2 of article 22 of the tax law by adding new

section 630-d. The  new  section  provides  for  the  Commissioner  of
Taxation  and  Finance to include a space on the individual income tax
return for contributions to Leukemia, Lymphoma, and Myeloma  research,
education  and treatment.  Section 4 - Amends the state finance law by
adding a new  section  97-1111.  The  new  section  provides  for  the
establishment of a special fund, consisting of revenues received under
section  209-i  and  630-d  of  the  tax  law  and  any  other  moneys
appropriated, credited or  transferred,  for  Leukemia,  Lymphoma  and
Myeloma  research,  education  and treatment. The custody of this fund
will be held jointly by the Commissioner of Taxation and  Finance  and
the  Comptroller. Further, the new section provides that all monies in
the fund to be used only for Leukemia, Lymphoma and Myeloma  research,
education and treatment programs approved by the Department of Health.
Additionally,  the  new  section  provides  that  the Comptroller must
approve releases of money that are certified by  the  Commissioner  of
Health  and that all money in the fund should be used prior to the end
of the fiscal year.

JUSTIFICATION:

Research  and  treatment  efforts   for   many   diseases,   including
Alzheimer's  and breast cancer, have benefited from additional funding
resulting from having a "check-off box" placed on the  individual  and
corporate income tax returns. Leukemia, Lymphoma and Myeloma are blood
cancers  originating  in the bone marrow and correlate with each other
because of the unrestrained growth  of  the  cells  and  the  parallel
functions which they possess. Leukemia, although more common in adults
over  the  age  of  64, is still the leading cause of disease death of
children under 15 yrs old, with Acute Lymphocytic Leukemia (ALL) being
the most common form of Leukemia in children. Treatment  advances  for
Leukemia  have  proven  to  be prevalent in the survival rate over the


years, with the survival rate increasing from 4% in  1960  to  85%  in
1999.  Lymphoma  involves  two particular forms including Non-Hodgkin,
which is the  fifth  most  common  cancer  in  the  U.S.  and  Hodgkin
Lymphoma,  which  mostly affects adolescents and young adults. Myeloma
occurs mostly in people over 60 yrs old with males having a 50% higher
chance than females of being diagnosed. Each year an estimated 106,200
people in the United States are diagnosed with Leukemia, Lymphoma,  or
Myeloma.    At  the  present time, an estimated 670,950 Americans have
blood cancers. Approximately 57,500  Americans  will  die  from  these
hematological  malignancies  this year. In New York State alone, there
are approximately 6,600 people diagnosed with a blood cancer each year
and 3,500 people will succumb to this disease.

PRIOR LEGISLATIVE HISTORY:

2012: A.0283-Passed Assembly S.0569- Died in Senate Health
2011: A.0283- Passed Assembly S.0569- Died in Senate Health
2010: A.3075- A Died on 3rd Rdg. S.1197-A - Died in Senate Health
2009: A.3075 Passed Assembly;
2008: A.1558-C Passed Assembly; S.3097-B Died in Senate Health
2007: A.1558-A Passed Assembly; S.3097-A-- Died in Senate Health
2006: A.3338-A Passed Assembly; S.2871-A-Died in Senate Health;
2005: A.3338-Passed Assembly; S.2878-A Died in Senate Health
2004: A.9816-Passed Assembly; S.6491-Died in Senate Health

FISCAL IMPLICATIONS:

Minimal to the state.

EFFECTIVE DATE:

This act shall apply to taxable years commencing on or  after  January
1, 2016.

2013-S1976B (ACTIVE) - Bill Text download pdf

                            
                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                 1976--B

                       2013-2014 Regular Sessions

                            I N  S E N A T E

                               (PREFILED)

                             January 9, 2013
                               ___________

Introduced by Sens. ROBACH, BRESLIN, MARCHIONE -- read twice and ordered
  printed,  and  when printed to be committed to the Committee on Health
  -- committee discharged, bill amended, ordered  reprinted  as  amended
  and  recommitted  to said committee -- recommitted to the Committee on
  Health  in  accordance  with  Senate  Rule  6,  sec.  8  --  committee
  discharged, bill amended, ordered reprinted as amended and recommitted
  to said committee

AN ACT to amend the public health law, the tax law and the state finance
  law, in relation to providing for taxpayer gifts for leukemia, lympho-
  ma  and myeloma research, education and treatment and establishing the
  leukemia, lymphoma and myeloma research, education and treatment fund

  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section  1.  The  public health law is amended by adding a new article
27-CCC to read as follows:
                             ARTICLE 27-CCC
LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION AND TREATMENT PROGRAM
SECTION 2747. LEUKEMIA, LYMPHOMA AND  MYELOMA  RESEARCH,  EDUCATION  AND
                TREATMENT.
  S  2747. LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION AND TREAT-
MENT.  THE COMMISSIONER SHALL ESTABLISH WITHIN THE DEPARTMENT A  PROGRAM
TO PROMOTE RESEARCH, EDUCATION AND TREATMENT REGARDING LEUKEMIA, LYMPHO-
MA  AND  MYELOMA. TO CARRY OUT THE PURPOSES OF THIS SECTION, THE COMMIS-
SIONER SHALL HAVE THE FOLLOWING POWERS AND DUTIES:
  1. TO PROMOTE RESEARCH, EDUCATION AND TREATMENT PROGRAMS  DESIGNED  TO
REDUCE  OR  PREVENT THE INCIDENCE AND SEVERITY OF LEUKEMIA, LYMPHOMA AND
MYELOMA;
  2. TO ACCEPT AND EXPEND ANY GRANTS, AWARDS OR OTHER FUNDS OR APPROPRI-
ATIONS AS MAY BE AVAILABLE FOR THESE PURPOSES SUBJECT TO LIMITATIONS  AS

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD00819-04-4

S. 1976--B                          2

TO  THE APPROVAL OF EXPENDITURES AND AUDIT AS PRESCRIBED FOR STATE FUNDS
BY THE STATE FINANCE LAW; AND
  3.  TO  ENTER  INTO CONTRACTS WITHIN THE AMOUNTS AVAILABLE THEREFOR AS
MAY BE NECESSARY TO IMPLEMENT THE PROVISIONS OF THIS SECTION.
  S 2. The tax law is amended by adding a new section 209-I to  read  as
follows:
  S  209-I.  GIFT FOR LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION
AND TREATMENT.  EFFECTIVE FOR ANY TAX YEAR COMMENCING ON OR AFTER  JANU-
ARY  FIRST,  TWO  THOUSAND  SIXTEEN,  A TAXPAYER IN ANY TAXABLE YEAR MAY
ELECT TO CONTRIBUTE TO THE SUPPORT OF THE LEUKEMIA, LYMPHOMA AND MYELOMA
RESEARCH, EDUCATION AND TREATMENT FUND. SUCH CONTRIBUTION  SHALL  BE  IN
ANY WHOLE DOLLAR AMOUNT AND SHALL NOT REDUCE THE AMOUNT OF THE STATE TAX
OWED  BY  SUCH  TAXPAYER.  THE  COMMISSIONER  SHALL INCLUDE SPACE ON THE
CORPORATE INCOME TAX RETURN TO ENABLE A TAXPAYER TO MAKE  SUCH  CONTRIB-
UTION.   NOTWITHSTANDING  ANY  OTHER  PROVISION  OF  LAW,  ALL  REVENUES
COLLECTED PURSUANT TO THIS SECTION SHALL BE CREDITED  TO  THE  LEUKEMIA,
LYMPHOMA AND MYELOMA RESEARCH, EDUCATION AND TREATMENT FUND AND SHALL BE
USED  ONLY FOR THOSE PURPOSES ENUMERATED IN SECTION NINETY-SEVEN-LLLL OF
THE STATE FINANCE LAW.
  S 3. The tax law is amended by adding a new section 630-d to  read  as
follows:
  S  630-D.  GIFT FOR LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION
AND TREATMENT.  EFFECTIVE FOR ANY TAX YEAR COMMENCING ON OR AFTER  JANU-
ARY  FIRST,  TWO THOUSAND SIXTEEN, AN INDIVIDUAL IN ANY TAXABLE YEAR MAY
ELECT TO CONTRIBUTE TO THE  LEUKEMIA,  LYMPHOMA  AND  MYELOMA  RESEARCH,
EDUCATION  AND  TREATMENT  FUND. SUCH CONTRIBUTION SHALL BE IN ANY WHOLE
DOLLAR AMOUNT AND SHALL NOT REDUCE THE AMOUNT OF STATE TAX OWED BY  SUCH
INDIVIDUAL.  THE COMMISSIONER SHALL INCLUDE SPACE ON THE PERSONAL INCOME
TAX RETURN TO ENABLE A TAXPAYER TO MAKE  SUCH  CONTRIBUTION.    NOTWITH-
STANDING  ANY  OTHER PROVISION OF LAW ALL REVENUES COLLECTED PURSUANT TO
THIS SECTION SHALL BE CREDITED TO THE  LEUKEMIA,  LYMPHOMA  AND  MYELOMA
RESEARCH,  EDUCATION AND TREATMENT FUND AND USED ONLY FOR THOSE PURPOSES
ENUMERATED IN SECTION NINETY-SEVEN-LLLL OF THE STATE FINANCE LAW.
  S 4. The state finance law is amended by adding a new section  97-llll
to read as follows:
  S  97-LLLL.  LEUKEMIA,  LYMPHOMA  AND  MYELOMA RESEARCH, EDUCATION AND
TREATMENT FUND. 1. THERE IS HEREBY ESTABLISHED IN THE JOINT  CUSTODY  OF
THE  COMMISSIONER OF TAXATION AND FINANCE AND THE COMPTROLLER, A SPECIAL
FUND TO BE KNOWN AS THE "LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCA-
TION AND TREATMENT FUND".
  2. SUCH FUND SHALL CONSIST OF ALL REVENUES RECEIVED BY THE  DEPARTMENT
OF  TAXATION  AND  FINANCE,  PURSUANT  TO  THE PROVISIONS OF SECTION TWO
HUNDRED NINE-I AND SECTION SIX HUNDRED THIRTY-D OF THE TAX LAW  AND  ALL
OTHER  MONEYS  APPROPRIATED,  CREDITED,  OR TRANSFERRED THERETO FROM ANY
OTHER FUND OR SOURCE PURSUANT TO LAW. NOTHING CONTAINED IN THIS  SECTION
SHALL PREVENT THE STATE FROM RECEIVING GRANTS, GIFTS OR BEQUESTS FOR THE
PURPOSES OF THE FUND AS DEFINED IN THIS SECTION AND DEPOSITING THEM INTO
THE FUND ACCORDING TO LAW.
  3.  MONIES  OF  THE FUND SHALL BE EXPENDED ONLY FOR LEUKEMIA, LYMPHOMA
AND MYELOMA RESEARCH, EDUCATION AND TREATMENT PROJECTS. AS USED IN  THIS
SECTION,  "LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION AND TREAT-
MENT PROJECTS" MEANS RESEARCH, EDUCATION AND TREATMENT PROJECTS, INCLUD-
ING GRANTS FOR LEUKEMIA, LYMPHOMA AND MYELOMA  RESEARCH,  EDUCATION  AND
TREATMENT,  WHICH,  PURSUANT TO SECTION TWENTY-SEVEN HUNDRED FORTY-SEVEN
OF THE PUBLIC HEALTH LAW, ARE APPROVED  BY  THE  DEPARTMENT  OF  HEALTH.

S. 1976--B                          3

SUCH  GRANTS  MAY  INCLUDE,  AMONG  OTHERS, GRANTS TO PUBLIC AND PRIVATE
HOSPITALS, MEDICAL CENTERS, MEDICAL SCHOOLS AND OTHER ORGANIZATIONS.
  4.  MONIES  SHALL BE PAYABLE FROM THE FUND ON THE AUDIT AND WARRANT OF
THE COMPTROLLER ON VOUCHERS APPROVED AND CERTIFIED BY  THE  COMMISSIONER
OF HEALTH.
  5.  TO THE EXTENT PRACTICABLE, THE COMMISSIONER OF HEALTH SHALL ENSURE
THAT ALL MONIES RECEIVED DURING A FISCAL YEAR ARE EXPENDED PRIOR TO  THE
END OF THAT FISCAL YEAR.
  S 5. This act shall take effect immediately and shall apply to taxable
years commencing on or after January 1, 2016.

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Senate Bill S1976B

Share this bill

Sponsored By

Joseph E. Robach

Archive: Last Bill Status - In Senate Committee Health Committee

Bill Amendments

co-Sponsors

Neil D. Breslin

2013-S1976 - Details

2013-S1976 - Summary

2013-S1976 - Sponsor Memo

2013-S1976 - Bill Text download pdf

co-Sponsors

Neil D. Breslin

Kathleen A. Marchione

2013-S1976A - Details

2013-S1976A - Summary

2013-S1976A - Sponsor Memo

2013-S1976A - Bill Text download pdf

co-Sponsors

Neil D. Breslin

Kathleen A. Marchione

2013-S1976B (ACTIVE) - Details

2013-S1976B (ACTIVE) - Summary

2013-S1976B (ACTIVE) - Sponsor Memo

2013-S1976B (ACTIVE) - Bill Text download pdf

Comments